These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3135514)

  • 21. Plasma levels of valproic acid and its metabolites during continued treatment in dogs.
    Löscher W
    J Vet Pharmacol Ther; 1981 Jun; 4(2):111-9. PubMed ID: 6818360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Daily variations in serum concentration of di-n-propyl-acetate in enteric soluble form (convulex): a study on 30 volunteers (author's transl)].
    Egli M; Wad N; Graf HP
    Schweiz Rundsch Med Prax; 1978 Jun; 67(26):974-80. PubMed ID: 353779
    [No Abstract]   [Full Text] [Related]  

  • 23. Bioavailability of a film-coated tablet of valproate in nonfasting volunteers.
    Ishikawa T; Horie M; Furuyama M; Ohuchi M; Awaya A; Sobajima H; Suchi M; Yamaguchi A; Okajima K; Wanibe M
    Jpn J Psychiatry Neurol; 1987 Dec; 41(4):693-8. PubMed ID: 3134567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicted serum valproic acid concentrations in patients missing and replacing a dose of extended-release divalproex sodium.
    Reed RC; Dutta S
    Am J Health Syst Pharm; 2004 Nov; 61(21):2284-9. PubMed ID: 15552636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divalproex-ER pharmacokinetics in older children and adolescents.
    Dutta S; Zhang Y; Conway JM; Sallee FR; Biton V; Reed MD; Kearns GL
    Pediatr Neurol; 2004 May; 30(5):330-7. PubMed ID: 15165635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is it preferable to prescribe 1 or 2 daily doses of sodium valproate?].
    Loiseau P; Levy RH; Guyot M; Morselli PL; Brachet-Liermain A
    Nouv Presse Med; 1982 Dec; 11(50):3693-6. PubMed ID: 6820492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases.
    Park MK; Lim KS; Kim TE; Han HK; Yi SJ; Shin KH; Cho JY; Shin SG; Jang IJ; Yu KS
    Ther Drug Monit; 2012 Oct; 34(5):599-603. PubMed ID: 22929406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
    Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH
    Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bioavailability of a valproic acid preparation. The relative bioavailability of enteric-resistant valproic acid preparations in tablet form with simultaneously administered tetradeuterated valproic acid as the bioavailability reference].
    Hoffmann F; Jancik BC; von Unruh GE
    Arzneimittelforschung; 1986 Jul; 36(7):1118-22. PubMed ID: 3094548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side effect profile of enteric-coated divalproex sodium versus valproic acid.
    Levine J; Chengappa KN; Parepally H
    J Clin Psychiatry; 2000 Sep; 61(9):680-1. PubMed ID: 11030493
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of Monte Carlo simulations to study the effect of poor compliance on the steady state concentrations of valproic acid following administration of enteric-coated and extended release divalproex sodium formulations.
    Ahmad AM; Douglas Boudinot F; Barr WH; Reed RC; Garnett WR
    Biopharm Drug Dispos; 2005 Dec; 26(9):417-25. PubMed ID: 16216031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of free serum valproate concentration: A prospective study in patients on divalproex sodium monotherapy.
    Nasreddine W; Dirani M; Atweh S; Makki A; Beydoun A
    Seizure; 2018 Jul; 59():24-27. PubMed ID: 29730272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal adverse effects with divalproex sodium and valproic acid.
    Wagner PG; Welton SR; Hammond CM
    J Clin Psychiatry; 2000 Apr; 61(4):302-3. PubMed ID: 10830155
    [No Abstract]   [Full Text] [Related]  

  • 35. Twice-daily dosing of valproate with divalproex.
    Wilder BJ; Karas BJ; Hammond EJ; Perchalski RJ
    Clin Pharmacol Ther; 1983 Oct; 34(4):501-4. PubMed ID: 6413118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding valproate to lamotrigine: a study of their pharmacokinetic interaction.
    Kanner AM; Frey M
    Neurology; 2000 Aug; 55(4):588-91. PubMed ID: 10953201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of saliva and serum free valproic acid concentrations in persons with epilepsy.
    Dwivedi R; Gupta YK; Singh M; Joshi R; Tiwari P; Kaleekal T; Tripathi M
    Seizure; 2015 Feb; 25():187-90. PubMed ID: 25455060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diurnal variations in steady-state plasma concentrations of valproic acid in epileptic patients.
    Loiseau P; Cenraud B; Levy RH; Akbaraly R; Brachet-Liermain A; Guyot M; Morselli PL
    Clin Pharmacokinet; 1982; 7(6):544-52. PubMed ID: 6819106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.